
ASP4132
CAS No. 1640294-30-9
ASP4132 ( —— )
产品货号. M22042 CAS No. 1640294-30-9
ASP4132 是一种口服活性 AMPK 激活剂 (EC50 : 18 nM),具有抗癌活性。
纯度: >98% (HPLC)






规格 | 价格/人民币 | 库存 | 数量 |
2MG | ¥713 | 有现货 |
![]() ![]() |
5MG | ¥1077 | 有现货 |
![]() ![]() |
10MG | ¥1677 | 有现货 |
![]() ![]() |
25MG | ¥3046 | 有现货 |
![]() ![]() |
50MG | ¥4560 | 有现货 |
![]() ![]() |
100MG | ¥6423 | 有现货 |
![]() ![]() |
200MG | 获取报价 | 有现货 |
![]() ![]() |
500MG | 获取报价 | 有现货 |
![]() ![]() |
1G | 获取报价 | 有现货 |
![]() ![]() |
生物学信息
-
产品名称ASP4132
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述ASP4132 是一种口服活性 AMPK 激活剂 (EC50 : 18 nM),具有抗癌活性。
-
产品描述ASP4132 is an orally active AMPK activator (EC50 : 18 nM), has anti-cancer activity.(In Vitro):ASP4132 shows comparable cell growth inhibitory (IC50=0.014 μM) activity against MDA-MB-453 breast cancer cell.ASP4132 shows relatively weak antiproliferative activity against SK-BR-3 (IC50>3 μM).(In Vivo):ASP4132 (0.5-8 mg/kg; PO; once daily; for 21 days) causes the tumor growth inhibition and regression.ASP4132 (1 mg/kg; IV or PO) has a T1/2 of 3.6 hours, a CLtot of 19 mL/min?kg, and a Vss of 4.6 L/kg for rats for IV.ASP4132 is stable in human liver microsomes (HLM CLint, vitro=61 mL/min?kg).
-
体外实验ASP4132 shows comparable cell growth inhibitory (IC50=0.014 μM) activity against MDA-MB-453 breast cancer cell. ASP4132 shows relatively weak antiproliferative activity against SK-BR-3 (IC50>3 μM).
-
体内实验ASP4132 (0.5-8 mg/kg; PO; once daily; for 21 days) causes the tumor growth inhibition and regression. ASP4132 (1 mg/kg; IV or PO) has a T1/2 of 3.6 hours, a CLtot of 19 mL/min?kg, and a Vss of 4.6 L/kg for rats for IV. ASP4132 is stable in human liver microsomes (HLM CLint, vitro=61 mL/min?kg). Animal Model:Five-week-old male nude mice with MDA-MB-453 Dosage:0.5, 1, 2, 4, 8 mg/kg Administration:PO; once daily; for 21 days Result:The tumor growth inhibition (TGI) rate was 29% at 1 mg/kg, and the tumor regression rate was 26%, 87% and 96% at 2, 4 and 8 mg/kg, respectively. Animal Model:Male SD rats Dosage:1 mg/kg (Pharmacokinetic Analysis) Administration:IV or PO Result:Had a T1/2 of 3.6 hours, a CLtot of 19 mL/min?kg, and a Vss of 4.6 L/kg for rats for IV. Had a Cmax of 72 ng/mL and an AUC24h of 705 ng?h/mL for PO.
-
同义词——
-
通路Membrane Transporter/Ion Channel
-
靶点AMPK
-
受体AMPK
-
研究领域——
-
适应症——
化学信息
-
CAS Number1640294-30-9
-
分子量937.06
-
分子式C46H51F3N6O8S2
-
纯度>98% (HPLC)
-
溶解度DMSO:230 mg/mL (245.45 mM; Need ultrasonic); Methanol:8.33 mg/mL (8.89 mM; Need ultrasonic)
-
SMILESCC1=CC=C(C=C1)S(O)(=O)=O.CC1=CC=C(C=C1)S(O)(=O)=O.COC1=CC=C(CN2CCC(CC2)C2=CC=C3N=C(NC3=C2)C(=O)N2CCN(CC3=CC=C(C=C3)C(F)(F)F)CC2)C=N1
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1. Kazuyuki Kuramoto , Yuki Sawada, Tomohiro Yamada,et al.Novel Indirect AMP-Activated Protein Kinase Activators: Identification of a Second-Generation Clinical Candidate with Improved Physicochemical Properties and Reduced hERG Inhibitory Activity.Chem Pharm Bull (Tokyo). 2020;68(5):452-465.